GeoVax Labs, Inc. (GOVX)
About GeoVax Labs, Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$21.5M
- Total assets
- $6.3M
- Market cap
- $8.6M
- Operating margin
- -869.3%
- Net margin
- -862.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $2.5M
- Operating expenses
- $24.1M
- Operating income
- -$21.6M
- Net income
- -$21.5M
- EPS (basic)
- $-22.40
Balance sheet
- Total assets
- $6.3M
- Current assets
- $5.3M
- Total liabilities
- $2.5M
- Current liabilities
- $1.9M
- Shareholders’ equity
- $3.8M
Cash flow
- Operating cash flow
- -$21.5M
- Investing cash flow
- -$27.6K
- Financing cash flow
- $19.1M
- Net cash flow
- -$2.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $8.6M
- Shares outstanding
- 11.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 1, 1995
GeoVax Labs, Inc. (GOVX) Stock Price
- Reported a net loss of $21.5M.
- Revenue grew 546% from FY2021 to FY2025.
- Trading 97% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review GeoVax Labs, Inc..
Write a review
News about GeoVax Labs, Inc.
News & sentiment via Polygon.io
GeoVax Labs, Inc.: frequently asked questions
Is GeoVax Labs, Inc. an American company?
GeoVax Labs, Inc. is a US-based company headquartered in Smyrna, Georgia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is GeoVax Labs, Inc. headquartered?
GeoVax Labs, Inc. is headquartered in Smyrna, Georgia, United States.
Is GeoVax Labs, Inc. publicly traded?
Yes — GeoVax Labs, Inc. is a publicly traded company. Its stock trades under the ticker symbol GOVX on the NASDAQ.
What does GeoVax Labs, Inc. do?
GeoVax Labs, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
